自身免疫性胰腺炎累及左侧髂血管旁组织1例报告

杨鑫; 李腊梅; 朱琦; 杨新乐; 王昕睿; 蔡艳俊; 李婉玉

doi:10.3969/j.issn.1001-5256.2022.12.026

自身免疫性胰腺炎累及左侧髂血管旁组织1例报告

DOI: 10.3969/j.issn.1001-5256.2022.12.026

吉林大学第一医院感染病与病原生物学中心肝胆胰内科，长春 130021

基金项目:

2017年吉林大学第一医院交叉学科创新项目 (JDYYJC006)

伦理学声明：本例报告已获得患者知情同意。

利益冲突声明：所有作者均声明不存在利益冲突。

作者贡献声明：杨鑫负责文献查询，文章思路形成及撰写；李腊梅、朱琦、杨新乐负责文献查询及数据收集分析；王昕睿、李婉玉负责提供文章选题；蔡艳俊提供文章修改意见；李婉玉负责拟定写作思路，课题设计及修改文章。

详细信息

通信作者:
李婉玉，liwanyu@mails.jlu.edu.cn

计量
- 文章访问数: 1284
- HTML全文浏览量: 921
- PDF下载量: 62
- 被引次数: 0
出版历程
- 收稿日期: 2022-03-31
- 录用日期: 2022-05-07
- 出版日期: 2022-12-20

Autoimmune pancreatitis involving left iliac paravascular tissue: A case report

Center for Infectious Diseases and Pathogen Biology, the First Hospital of Jilin University, Changchun 130021, China

Research funding:

2017 Interdisciplinary Innovation Project of the First Hospital of Jilin University (JDYYJC006)

More Information

Corresponding author: LI Wanyu, liwanyu@mails.jlu.edu.cn (ORCID: 0000-0002-0706-7019)

摘要

- 自身免疫性胰腺炎 /
- 髂血管旁组织 /
- 治疗学
- Autoimmune Pancreatitis /
- Iliac Paravascular Tissue /
- Therapeutics

HTML全文

图 1 CT提示胰头占位性病变及盆底软组织影

注：a，箭头所示为治疗前胰腺病变；b，箭头所示为治疗前软组织病变；c，箭头所示为激素治疗后胰腺病变；d，箭头所示为激素治疗后软组织病变。

Figure 1. CT showed space occupying lesion of pancreatic head and soft tissue shadow of pelvic floor

下载: 全尺寸图片幻灯片

图 2 PET/CT提示胰头区、左侧髂血管旁软组织增厚伴代谢增高

注：a，箭头所示为胰头病变；b，箭头所示为软组织病变。

Figure 2. PET/CT showed soft tissue thickening in the pancreatic head area and left iliac paravascular area with increased metabolism

下载: 全尺寸图片幻灯片

图 3 患者肝功能及IgG4变化趋势图

注：a，2021年11月22日；b，2021年11月30日；c，2021年12月9日；d，2022年1月8日；e，2022年2月15日。

Figure 3. Changing trend of liver function and IgG4 in patient

下载: 全尺寸图片幻灯片

参考文献(24)

[1]	MA J, LIU YL. Corticosteroid therapy for autoimmune pancreatitis[J]. J Clin Hepatol, 2018, 34(8): 1599-1603. DOI: 10.3969/j.issn.1001-5256.2018.08.002. 马娟, 刘玉兰. 自身免疫性胰腺炎的激素治疗[J]. 临床肝胆病杂志, 2018, 34(8): 1599-1603. DOI: 10.3969/j.issn.1001-5256.2018.08.002.
[2]	MASAKI Y, DONG L, KUROSE N, et al. Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders[J]. Ann Rheum Dis, 2009, 68(8): 1310-1315. DOI: 10.1136/ard.2008.089169.
[3]	DESHPANDE V, ZEN Y, CHAN JK, et al. Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol, 2012, 25(9): 1181-1192. DOI: 10.1038/modpathol.2012.72.
[4]	KHOSROSHAHI A, WALLACE ZS, CROWE JL, et al. International consensus guidance statement on the management and treatment of IgG4-related disease[J]. Arthritis Rheumatol, 2015, 67(7): 1688-1699. DOI: 10.1002/art.39132.
[5]	STONE JH, KHOSROSHAHI A, DESHPANDE V, et al. Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations[J]. Arthritis Rheum, 2012, 64(10): 3061-3067. DOI: 10.1002/art.34593.
[6]	LI W, CHEN Y, SUN Z P, et al. Clinicopathological characteristics of immunoglobulin G4-related sialadenitis[J]. Arthritis Res Ther, 2015, 17(1): 186. DOI: 10.1186/s13075-015-0698-y.
[7]	LIU Y, XUE M, WANG Z, et al. Salivary gland involvement disparities in clinical characteristics of IgG4-related disease: a retrospective study of 428 patients[J]. Rheumatology (Oxford), 2020, 59(3): 634-640. DOI: 10.1093/rheumatology/kez280.
[8]	Editorial board of Chinese Journal of pancreatic diseases. Chinese consus on autoimune pancreatitis (Draft 2012, Shanghai)[J]. Chin J Pancreatol, 2012, 12(6): 410-418. DOI: 10.3760/cma.j.issn.1674-1935.2012.06.017. 《中华胰腺病杂志》编委会. 我国自身免疫性胰腺炎共识意见(草案2012, 上海)[J]. 中华胰腺病杂志, 2012, 12(6): 410-418. DOI: 10.3760/cma.j.issn.1674-1935.2012.06.017.
[9]	CAI O, TAN S. From pathogenesis, clinical manifestation, and diagnosis to treatment: an overview on autoimmune pancreatitis[J]. Gastroenterol Res Pract, 2017, 2017: 3246459. DOI: 10.1155/2017/3246459.
[10]	MARUYAMA M, WATANABE T, KANAI K, et al. International consensus diagnostic criteria for autoimmune pancreatitis and its Japanese amendment have improved diagnostic ability over existing criteria[J]. Gastroenterol Res Pract, 2013, 2013: 456965. DOI: 10.1155/2013/456965.
[11]	LUO Y, PAN Q, YANG H, et al. Fibroblast activation protein-targeted PET/CT with 68Ga-FAPI for imaging IgG4-related disease: Comparison to 18F-FDG PET/CT[J]. J Nucl Med, 2021, 62(2): 266-271. DOI: 10.2967/jnumed.120.244723.
[12]	SAHANI DV, KALVA SP, FARRELL J, et al. Autoimmune pancreatitis: imaging features[J]. Radiology, 2004, 233(2): 345-352. DOI: 10.1148/radiol.2332031436.
[13]	MIZUSHIMA I, KASASHIMA S, FUJINAGA Y, et al. IgG4-related periaortitis/periarteritis: An under-recognized condition that is potentially life-threatening[J]. Mod Rheumatol, 2019, 29(2): 240-250. DOI: 10.1080/14397595.2018.1546367.
[14]	ZHANG J, CHEN H, MA Y, et al. Characterizing IgG4-related disease with ¹⁸F-FDG PET/CT: a prospective cohort study[J]. Eur J Nucl Med Mol Imaging, 2014, 41(8): 1624-1634. DOI: 10.1007/s00259-014-2729-3.
[15]	VLACHOU PA, KHALILI K, JANG HJ, et al. IgG4-related sclerosing disease: autoimmune pancreatitis and extrapancreatic manifestations[J]. Radiographics, 2011, 31(5): 1379-1402. DOI: 10.1148/rg.315105735.
[16]	INOUE D, YOSHIDA K, YONEDA N, et al. IgG4-related disease: dataset of 235 consecutive patients[J]. Medicine (Baltimore), 2015, 94(15): e680. DOI: 10.1097/MD.0000000000000680.
[17]	PENG L, ZHANG P, LI J, et al. IgG4-related aortitis/periaortitis and periarteritis: a distinct spectrum of IgG4-related disease[J]. Arthritis Res Ther, 2020, 22(1): 103. DOI: 10.1186/s13075-020-02197-w.
[18]	PERUGINO CA, WALLACE ZS, MEYERSOHN N, et al. Large vessel involvement by IgG4-related disease[J]. Medicine (Baltimore), 2016, 95(28): e3344. DOI: 10.1097/MD.0000000000003344.
[19]	INOUE D, ZEN Y, ABO H, et al. Immunoglobulin G4-related periaortitis and periarteritis: CT findings in 17 patients[J]. Radiology, 2011, 261(2): 625-633. DOI: 10.1148/radiol.11102250.
[20]	KANNO A, NISHIMORI I, MASAMUNE A, et al. Nationwide epidemiological survey of autoimmune pancreatitis in Japan[J]. Pancreas, 2012, 41(6): 835-839. DOI: 10.1097/MPA.0b013e3182480c99.
[21]	VAGLIO A, SALVARANI C, BUZIO C. Retroperitoneal fibrosis[J]. The Lancet, 2006, 367(9506): 241-251. DOI: 10.1016/S0140-6736(06)68035-5.
[22]	LIN W, LU S, CHEN H, et al. Clinical characteristics of immunoglobulin G4-related disease: a prospective study of 118 Chinese patients[J]. Rheumatology (Oxford), 2015, 54(11): 1982-1990. DOI: 10.1093/rheumatology/kev203.
[23]	WANG K, WANG Z, ZENG Q, et al. Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis[J]. PLoS One, 2021, 16(2): e0245601. DOI: 10.1371/journal.pone.0245601.
[24]	PERUGINO CA, WALLACE ZS, MEYERSOHN N, et al. Large vessel involvement by IgG4-related disease[J]. Medicine (Baltimore), 2016, 95(28): e3344. DOI: 10.1097/MD.0000000000003344.